Mwandishi:
ULY CLINIC
Mhariri:
ULY CLINIC
Imeboreshwa;
27 Juni 2026, 04:25:07
Blood transfusion in Sickle Cell Disease
Blood Transfusion in Sickle Cell Disease
Simple (Top-Up) Blood Transfusion
Simple transfusion is indicated in patients with symptomatic anaemia or when the haemoglobin concentration has fallen by >2 g/dL below the patient's steady-state baseline.
Exchange Blood Transfusion
The goal of exchange transfusion is to reduce HbS to ≤30% while avoiding excessive increases in total haemoglobin and blood viscosity.
Indications
Acute ischemic stroke or other cerebrovascular events
Acute chest syndrome (moderate to severe)
Major surgery requiring general anaesthesia
Multi-organ failure, including systemic marrow fat embolism syndrome
Multiple pregnancy in selected high-risk patients
Secondary prevention of recurrent stroke
Relative indications
Recurrent severe vaso-occlusive crises refractory to optimal medical therapy
Severe or prolonged priapism unresponsive to standard treatment
Important Considerations
Routine transfusion is not recommended for patients in steady-state sickle cell disease solely because the haemoglobin level is 8–10 g/dL, as these patients are physiologically adapted to chronic anaemia.
Packed red blood cells (PRBCs) are preferred over whole blood to minimize the risk of volume overload.
Avoid raising the haemoglobin concentration above 10–11 g/dL with simple transfusion to reduce the risk of hyperviscosity.
Blood should be appropriately cross-matched, and patients should be monitored for transfusion reactions, alloimmunization, iron overload, and transfusion-transmitted infections.
Exchange transfusion is preferred over simple transfusion when rapid reduction of HbS is required without significantly increasing blood viscosity.
Updated on,
